Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Assessment of efficacy of dendritic cell therapy and viral therapy in high grade glioma clinical trials. A meta-analytic review.

Vatu BI, Artene SA, Staicu AG, Turcu-Stiolica A, Folcuti C, Dragoi A, Cioc C, Baloi SC, Tataranu LG, Silosi C, Dricu A.

J Immunoassay Immunochem. 2019;40(1):70-80. doi: 10.1080/15321819.2018.1551804. Epub 2018 Nov 30.

PMID:
30497337
2.

Warmth and competence predict overoptimistic beliefs for out-group but not in-group members.

Dricu M, Bührer S, Hesse F, Eder C, Posada A, Aue T.

PLoS One. 2018 Nov 26;13(11):e0207670. doi: 10.1371/journal.pone.0207670. eCollection 2018.

3.

Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials.

Artene SA, Turcu-Stiolica A, Ciurea ME, Folcuti C, Tataranu LG, Alexandru O, Purcaru OS, Tache DE, Boldeanu MV, Silosi C, Dricu A.

Sci Rep. 2018 Aug 7;8(1):11800. doi: 10.1038/s41598-018-30296-x.

4.

Recent challenges with stem cell banking.

Dricu A.

Expert Opin Biol Ther. 2018 Apr;18(4):355-358. doi: 10.1080/14712598.2018.1445715. Epub 2018 Feb 26. No abstract available.

PMID:
29474794
5.

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

Alexandru O, Purcaru SO, Tataranu LG, Lucan L, Castro J, Folcuţi C, Artene SA, Tuţă C, Dricu A.

Int J Mol Sci. 2018 Jan 12;19(1). pii: E229. doi: 10.3390/ijms19010229.

6.

Current and emerging EGFR therapies for glioblastoma.

Artene SA, Tuţă C, Dragoi A, Alexandru O, Stefana Oana P, Tache DE, Dănciulescu MM, Boldeanu MV, Siloşi CA, Dricu A.

J Immunoassay Immunochem. 2018;39(1):1-11. doi: 10.1080/15321819.2017.1411816. Epub 2018 Feb 2. Review.

PMID:
29308973
7.

Biased and unbiased perceptual decision-making on vocal emotions.

Dricu M, Ceravolo L, Grandjean D, Frühholz S.

Sci Rep. 2017 Nov 24;7(1):16274. doi: 10.1038/s41598-017-16594-w.

8.

Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation.

Suleymanova N, Crudden C, Worrall C, Dricu A, Girnita A, Girnita L.

Oncotarget. 2017 Jul 17;8(47):82256-82267. doi: 10.18632/oncotarget.19286. eCollection 2017 Oct 10.

9.

Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.

Siloşi I, Boldeanu L, Biciuşcă V, Bogdan M, Avramescu C, Taisescu C, Padureanu V, Boldeanu MV, Dricu A, Siloşi CA.

Int J Mol Sci. 2017 Jun 19;18(6). pii: E1304. doi: 10.3390/ijms18061304.

10.

β-arrestin 1 Overexpression Increases Temozolomide Resistance in Human Malignant Glioma Cells.

Artene SA, Folcuti C, Dricu A.

Curr Health Sci J. 2017 Apr-Jun;43(2):112-119. doi: 10.12865/CHSJ.43.02.02. Epub 2017 Jun 29.

11.

Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis.

Artene SA, Turcu-Stiolica A, Hartley R, Ciurea ME, Daianu O, Brindusa C, Alexandru O, Tataranu LG, Purcaru SO, Dricu A.

Onco Targets Ther. 2016 Nov 4;9:6669-6677. eCollection 2016.

12.

Perceiving emotional expressions in others: Activation likelihood estimation meta-analyses of explicit evaluation, passive perception and incidental perception of emotions.

Dricu M, Frühholz S.

Neurosci Biobehav Rev. 2016 Dec;71:810-828. doi: 10.1016/j.neubiorev.2016.10.020. Epub 2016 Nov 9. Review.

PMID:
27836460
13.

The effect of curcumin on low-passage glioblastoma cells in vitro.

Alexandru O, Georgescu AM, Ene L, Purcaru SO, Serban F, Popescu A, Brindusa C, Tataranu LG, Ciubotaru V, Dricu A.

J Cancer Res Ther. 2016 Apr-Jun;12(2):1025-32. doi: 10.4103/0973-1482.167609.

14.

Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.

Serban F, Daianu O, Tataranu LG, Artene SA, Emami G, Georgescu AM, Alexandru O, Purcaru SO, Tache DE, Danciulescu MM, Sfredel V, Dricu A.

J Immunoassay Immunochem. 2017;38(1):21-33. doi: 10.1080/15321819.2016.1209217. Epub 2016 Jul 5.

PMID:
27379831
15.

New perspectives in glioblastoma antiangiogenic therapy.

Popescu AM, Purcaru SO, Alexandru O, Dricu A.

Contemp Oncol (Pozn). 2016;20(2):109-18. doi: 10.5114/wo.2015.56122. Epub 2015 Dec 8. Review.

16.

Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker.

Serban F, Artene SA, Georgescu AM, Purcaru SO, Tache DE, Alexandru O, Dricu A.

Onco Targets Ther. 2015 Dec 16;8:3767-74. doi: 10.2147/OTT.S93843. eCollection 2015. Review.

17.

The Effect of Human Mesenchymal Stem Cells-Conditioned Media on Glioblastoma Cells Viability In Vitro.

Folcuti RM, Silosi I, Purcaru SO, Tache DE, Georgescu AM, Emami GH, Dricu A.

Curr Health Sci J. 2015 Oct-Dec;41(4):339-344. doi: 10.12865/CHSJ.41.04.08. Epub 2015 Dec 22.

18.

Effect of VEGFR, PDGFR and PI3K/mTOR Targeting in Glioblastoma.

Purcaru SO, Tache DE, Serban F, Folcuti RM, Georgescu AM, Stovicek PO, Danciulescu MM, Tataranu LG, Dricu A.

Curr Health Sci J. 2015 Oct-Dec;41(4):325-332. doi: 10.12865/CHSJ.41.04.06. Epub 2015 Dec 22.

19.

Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.

Popescu AM, Alexandru O, Brindusa C, Purcaru SO, Tache DE, Tataranu LG, Taisescu C, Dricu A.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):7825-37. eCollection 2015.

20.

Correlation between Tgf-Β1 and Fsp-1 Expression in Chronic Viral Hepatitis - an Immunohistochemical Study.

Tache DE, Firu ŞG, Andrei AM, Predescu A, Purcaru ŞO, Dobrescu AM, Dricu A, Pisoschi CG, Stănciulescu EC.

Curr Health Sci J. 2015 Apr-Jun;41(2):179-185. doi: 10.12865/CHSJ.41.02.14. Epub 2015 Apr 10.

Supplemental Content

Loading ...
Support Center